Your browser doesn't support javascript.
loading
Mast Cell Deficiency Protects Susceptible BALB/c Mice from Progressive Murine Cutaneous Leishmaniasis.
Dietze-Schwonberg, Kirsten; Lorenz, Beate; Hartmann, Ann-Kathrin; Stassen, Michael; von Stebut, Esther.
Affiliation
  • Dietze-Schwonberg K; Department of Dermatology, University Hospital of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Lorenz B; Department of Dermatology, University Hospital Cologne, Cologne, Germany.
  • Hartmann AK; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Paul-Klein-Center for Immune Intervention, Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Stassen M; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Paul-Klein-Center for Immune Intervention, Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Mainz, Mainz, Germany.
  • von Stebut E; Department of Dermatology, University Hospital Cologne, Cologne, Germany. Electronic address: esther.von-stebut@uk-koeln.de.
J Invest Dermatol ; 141(2): 450-453, 2021 02.
Article in En | MEDLINE | ID: mdl-32681925

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmaniasis, Cutaneous / Leishmania major / Disease Susceptibility / Mast Cells Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Invest Dermatol Year: 2021 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmaniasis, Cutaneous / Leishmania major / Disease Susceptibility / Mast Cells Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Invest Dermatol Year: 2021 Type: Article Affiliation country: Germany